Nasopharyngeal Carcinoma in Children and Adolescents: Single Institution Study

서지정보

· 발행기관 : 대한소아혈액종양학회
· 수록지 정보 : Clinical Pediatric Hematology-Oncology / 21권 / 2호 / 114 ~ 120페이지
· 저자명 : 최정윤, 강형진, 주희영, 홍채리, 김일환, 박성혜, 김인원, 박경덕, 신희영

초록

Background: Nasopharyngeal carcinoma (NPC) is very rare in children and adolescents. The aim of this study was to evaluate clinical characteristics and treatment outcomes of pediatric NPC.
Methods: Medical records of 9 patients treated for NPC at the Seoul National University Children’s Hospital between 1988 and 2012 were analyzed retrospectively.
Results: The median age at diagnosis was 11 years (range, 9–13 years). One patient had stage II disease, 3 had stage III disease, and 5 had stage IV disease. The histologic subtypes were undifferentiated carcinoma and squamous cell carcinoma in 7 and 2 patients, respectively. All patients were initially treated with cisplatin (100 mg/m2 intravenous [IV] every 4 weeks for 4–6 months), bleomycin (15 unit/m2 IV every 1 week×7), and fluorouracil (1,000 mg/m2 IV every 4 weeks for 1 year). Eight patients received radiotherapy with doses of 45-59.4 Gy at the primary site and neck nodes. Seven patients (77.8%) achieved complete remission, 1 (11.1%) achieved partial remission, and 1 (11.1%) showed disease progression. Six patients developed fluorouracil-related neurotoxicity; the regimen was changed to cisplatin, epirubicin, and bleomycin in five of the 6 patients. One patient died of progressive disease without responding to treatment. Treatment-related mortality occurred in 1 patient owing to septic shock. Secondary osteosarcoma developed in 1 patient 6 years after treatment. The overall survival was 77.8%, with a median follow-up of 40.8 months (range, 4.5-287.6 months).
Conclusion: Children and adolescents with advanced NPC treated with combined chemotherapy and radiotherapy have a good survival rate.

참고자료

· 없음